# Bitwise Ethereum ETF: financial statements, quarterly

ETHW · NYSE · CIK 2013744 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ethw.md) · [Financials](/companies/ethw/financials.md) · [Filings](/companies/ethw/filings.md) · [Insiders](/companies/ethw/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ethw/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $m | [0.0 d](/filings/0000950170-24-124133.md) | [0.0 d](/filings/0001193125-25-274499.md) | [0.0](/filings/0000950170-25-068774.md) | [0.0 d](/filings/0000950170-25-105121.md) | [0.0 d](/filings/0001193125-25-274499.md) | [0.0 d](/filings/0001193125-26-104221.md) | [0.0](/filings/0001193125-26-209331.md) | [0.0 d](/filings/0001193125-26-340188.md) |
| Net income | $m | not reported | not reported | [(150)](/filings/0001193125-26-209331.md) | [61.9](/filings/0001193125-26-340188.md) | [188](/filings/0001193125-25-274499.md) | [(154) d](/filings/0001193125-26-104221.md) | [(111)](/filings/0001193125-26-209331.md) | [(54.8)](/filings/0001193125-26-340188.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0000950170-24-093596.md) | [0.0](/filings/0000950170-24-124133.md) | [0.0](/filings/0001193125-26-104221.md) | [0.0](/filings/0000950170-25-068774.md) | [0.0](/filings/0000950170-25-105121.md) | [0.0](/filings/0001193125-25-274499.md) | [0.0](/filings/0001193125-26-209331.md) | [0.0](/filings/0001193125-26-209331.md) | not reported |
| Total assets | $m | [0.0](/filings/0000950170-24-093596.md) | [260](/filings/0000950170-24-124133.md) | [405](/filings/0001193125-26-104221.md) | [174](/filings/0000950170-25-068774.md) | [269](/filings/0000950170-25-105121.md) | [500](/filings/0001193125-25-274499.md) | [344](/filings/0001193125-26-340188.md) | [220](/filings/0001193125-26-209331.md) | [168](/filings/0001193125-26-340188.md) |
| Total liabilities | $m | [0.0](/filings/0000950170-24-093596.md) | [0.0](/filings/0000950170-24-124133.md) | [0.0](/filings/0001193125-26-104221.md) | [0.0](/filings/0000950170-25-068774.md) | [0.0](/filings/0000950170-25-105121.md) | [0.1](/filings/0001193125-25-274499.md) | [0.1](/filings/0001193125-26-340188.md) | [1.2](/filings/0001193125-26-209331.md) | [0.0](/filings/0001193125-26-340188.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [80.8](/filings/0001193125-26-209331.md) | [(33.3) d](/filings/0001193125-26-340188.md) | [(43.2) d](/filings/0001193125-25-274499.md) | [1.7 d](/filings/0001193125-26-104221.md) | [10.0](/filings/0001193125-26-209331.md) | [(5.2) d](/filings/0001193125-26-340188.md) |
| Share repurchases | $m | [104](/filings/0001193125-26-209331.md) | [16.2 d](/filings/0001193125-26-340188.md) | [287 d](/filings/0001193125-25-274499.md) | [179 d](/filings/0001193125-26-104221.md) | [113](/filings/0001193125-26-209331.md) | [13.4 d](/filings/0001193125-26-340188.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 14,870,000 at 2026-08-02, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-340188.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.